Centessa Pharmaceuticals plc (CNTA)
NASDAQ·Healthcare·Biotechnology
$39.50
-0.04%
Mkt Cap $3.51B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $1.02M | — | — | -$0.37 | -$0.48 | -29.23% | — | — |
| Q4 2025 Nov 5, 2025 | $767.00K | — | — | -$0.39 | -$0.41 | -5.13% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.35 | -$0.38 | -8.57% | — | — |
| Q2 2025 May 14, 2025 | $2.14M | $15.00M | +600.00% | -$0.35 | -$0.20 | +42.86% | — | — |
| Q1 2025 Mar 24, 2025 | — | $952.25K | — | -$0.38 | -$0.34 | +10.53% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.42 | -$0.37 | +11.90% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.38 | -$0.40 | -5.26% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.41 | -$0.38 | +7.32% | — | — |
| Q1 2024 Mar 28, 2024 | — | $6.91M | — | -$0.44 | -$0.38 | +13.64% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.46 | -$0.40 | +13.04% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.43 | -$0.26 | +39.53% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$0.41 | -$0.53 | -29.27% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.48 | -$0.45 | +6.25% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.49 | -$0.57 | -16.33% | — | — |
| Q3 2022 Aug 10, 2022 | — | — | — | -$0.56 | -$0.69 | -23.21% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.70 | -$0.60 | +14.29% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.60 | -$0.68 | -13.33% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.55 | -$0.45 | +18.18% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.73 | -$0.65 | +10.96% | — | — |
| Q2 2021 Jun 1, 2021 | — | — | — | — | -$2.75 | — | — | — |